PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway.
about
Systematic Classification of Mixed-Lineage Leukemia Fusion Partners Predicts Additional Cancer PathwaysHoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid LeukemiaTwo decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia.PU.1 affects proliferation of the human acute myeloid leukemia U937 cell line by directly regulating MEIS1.JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors.MLL1 and MLL1 fusion proteins have distinct functions in regulating leukemic transcription programTranscriptional regulation of the proto-oncogene Zfp521 by SPI1 (PU.1) and HOXC13.The RUNX1-PU.1 axis in the control of hematopoiesis.Molecular Malfeasance Mediating Myeloid Malignancies: The Genetics of Acute Myeloid Leukemia.Vitamin C-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia.The full transforming capacity of MLL-Af4 is interlinked with lymphoid lineage commitment.The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemia.Deregulation of the HOXA9/MEIS1 axis in acute leukemia.A tale of TALE, PREP1, PBX1, and MEIS1: Interconnections and competition in cancer.The IRX1/HOXA connection: insights into a novel t(4;11)- specific cancer mechanismSenescence is a Spi1-induced anti-proliferative mechanism in primary hematopoietic cells.The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias.Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia.Transcription factor PU.1 is involved in the progression of glioma.
P2860
Q26771880-FE78B776-10BB-4BCC-A45F-081828FB11E6Q33558976-954CA454-EE01-4B09-9DAE-DB12409C553BQ35018755-3A65520D-8381-4176-B669-01E0BF2C40DEQ35944525-6E8DF7B3-8C59-44EA-950D-E7B3FB689204Q36199628-1E895D25-1425-40C3-854C-7AB408182E16Q36906949-B0EA8A59-2657-403B-A454-BDB517798F0DQ37354907-FE4E8D3C-638B-46CE-A251-1F07965EFE7FQ38370113-C79E046F-EE14-4F51-BABE-D75FEB9DAFB7Q38653160-947A263E-11D0-437E-B71F-2658805905AEQ38701483-8B286F4B-C792-46F3-B8D4-4398888F325EQ38715114-CA2CDE7F-54A2-49D4-A783-36C111B3CB42Q38739798-AC66F641-AF62-48DE-98C1-241F481CF3ACQ38852979-A5F93555-CC31-4F57-8CB8-87B56C499EF3Q38891359-37D4B7D6-801C-4C68-BC63-D2D69FEFA41BQ41610527-EC80CEAB-DE35-4F75-82D8-CB7A4C9795D9Q43539014-828D9781-570B-4CB0-9029-AA2469F070BAQ48151269-0785595A-8262-443D-926A-4377470FD47DQ48186371-B840B39C-A383-4313-8437-FA5EA8F48A3DQ50324029-47231FB1-EAD7-400C-9362-AAB91DE0E8AC
P2860
PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway.
@ast
PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway.
@en
type
label
PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway.
@ast
PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway.
@en
prefLabel
PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway.
@ast
PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway.
@en
P2093
P2860
P356
P1433
P1476
PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway
@en
P2093
B Löwenberg
P2860
P2888
P304
P356
10.1038/LEU.2013.384
P577
2013-12-26T00:00:00Z